health
Bispecific biologic reactivates latent HIV-1 and SIV in preclinical tests
A bioRxiv preprint reports that the bispecific biologic T4IL15∆ reactivated latent virus in clinical samples, HIV-1-infected humanized mice and SIV-infected macaques. The results are from ex vivo and animal studies, not treatment in people.